Neurocognitive Function and Health-Related Quality of Life in Pediatric Korean Survivors of Medulloblastoma
- PMID: 27709849
- PMCID: PMC5056203
- DOI: 10.3346/jkms.2016.31.11.1726
Neurocognitive Function and Health-Related Quality of Life in Pediatric Korean Survivors of Medulloblastoma
Abstract
The neurocognitive function and quality of life of 58 Korean survivors of childhood medulloblastoma were assessed after surgery, cranial radiation and chemotherapy. All patients were evaluated with a battery of neurocognitive function tests and the Pediatric Functional Assessment of Cancer Therapy-Brain Tumor Survivors, which consists of self-report questionnaires on quality of life. The mean full-scale intelligence quotient (IQ), verbal IQ, and performance IQ scores were 90.2, 97.1, and 84.16, respectively. The mean memory quotient (MQ) score was 86.78, which was within 1 standard deviation of the average score of 100. Processing speed, attention, and executive function showed mild to moderate deficits. Intelligence, memory, executive function, visuospatial function, and simple motor function were significantly lower in the patients diagnosed before 8 years of age compared with those diagnosed after 8. The cognitive deficits in the patients diagnosed at younger ages might be related to earlier exposure to craniospinal irradiation and chemotherapy. The patient and parent proxy evaluations of attention, fine motor function, and quality of life did not differ. We found significant neurocognitive changes in a wide range of neurocognitive functional domains in Korean survivors of childhood medulloblastoma. Long-term follow-up studies of survivors of childhood medulloblastoma beginning at the time of their first diagnosis are required to better understand the deficits exhibited by survivors of childhood medulloblastoma, so that intervention strategies and treatment refinements that reduce the long-term neurocognitive decline can be developed.
Keywords: Cognition; Korea; Medulloblastoma; Quality of Life; Survivors.
Conflict of interest statement
The authors have no potential conflicts of interest to disclose.
Figures


Similar articles
-
Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma.J Neurooncol. 2005 May;72(3):245-53. doi: 10.1007/s11060-004-3009-z. J Neurooncol. 2005. PMID: 15937648
-
Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood.Pediatr Neurosurg. 2005 Jan-Feb;41(1):15-21. doi: 10.1159/000084860. Pediatr Neurosurg. 2005. PMID: 15886508
-
Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning.J Clin Oncol. 2022 Jan 1;40(1):83-95. doi: 10.1200/JCO.21.01480. Epub 2021 Oct 29. J Clin Oncol. 2022. PMID: 34714708 Free PMC article.
-
Cognitive disorders in pediatric medulloblastoma: what neuroimaging has to offer.J Neurosurg Pediatr. 2014 Aug;14(2):136-44. doi: 10.3171/2014.5.PEDS13571. Epub 2014 Jun 20. J Neurosurg Pediatr. 2014. PMID: 24950472 Review.
-
Medulloblastoma: clinical and biologic aspects.Neuro Oncol. 1999 Jul;1(3):232-50. doi: 10.1093/neuonc/1.3.232. Neuro Oncol. 1999. PMID: 11550316 Free PMC article. Review.
Cited by
-
Computerized assessment of neuropsychological functioning in pediatric brain tumor patients.J Neurooncol. 2025 May;172(3):633-644. doi: 10.1007/s11060-025-04945-x. Epub 2025 Jan 31. J Neurooncol. 2025. PMID: 39888549
-
Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies with Clinical Risk Stratification.J Korean Med Sci. 2022 Feb 21;37(7):e59. doi: 10.3346/jkms.2022.37.e59. J Korean Med Sci. 2022. PMID: 35191235 Free PMC article.
-
Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma.Cancer Med. 2020 Aug;9(16):5807-5818. doi: 10.1002/cam4.3199. Epub 2020 Jun 30. Cancer Med. 2020. PMID: 32608158 Free PMC article.
-
Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort.Cancer Med. 2020 Jan;9(2):447-459. doi: 10.1002/cam4.2701. Epub 2019 Nov 21. Cancer Med. 2020. PMID: 31755223 Free PMC article.
-
Quality of life in survivors of pediatric medulloblastoma: a systematic review and meta-analysis.Childs Nerv Syst. 2023 May;39(5):1159-1171. doi: 10.1007/s00381-023-05886-4. Epub 2023 Feb 24. Childs Nerv Syst. 2023. PMID: 36826523
References
-
- Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol. 2004;22:706–713. - PubMed
-
- Kieffer-Renaux V, Viguier D, Raquin MA, Laurent-Vannier A, Habrand JL, Dellatolas G, Kalifa C, Hartmann O, Grill J. Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors. Pediatr Blood Cancer. 2005;45:814–819. - PubMed
-
- Khong PL, Leung LH, Fung AS, Fong DY, Qiu D, Kwong DL, Ooi GC, McAlonan G, Cao G, Chan GC. White matter anisotropy in post-treatment childhood cancer survivors: preliminary evidence of association with neurocognitive function. J Clin Oncol. 2006;24:884–890. - PubMed
-
- Rønning C, Sundet K, Due-Tønnessen B, Lundar T, Helseth E. Persistent cognitive dysfunction secondary to cerebellar injury in patients treated for posterior fossa tumors in childhood. Pediatr Neurosurg. 2005;41:15–21. - PubMed
-
- Maddrey AM, Bergeron JA, Lombardo ER, McDonald NK, Mulne AF, Barenberg PD, Bowers DC. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol. 2005;72:245–253. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources